TrialDiabetes, obesity & metabolism2020

Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII).

Linong Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.